trending Market Intelligence /marketintelligence/en/news-insights/trending/vgqgopbsk94vrz6-mkfagg2 content esgSubNav
In This List

Dextera completes sale of assets under bankruptcy filing

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Dextera completes sale of assets under bankruptcy filing

Dextera Surgical Inc. sold its assets to B. Braun Group's Aesculap Inc., after filing for bankruptcy in December 2017.

Aesculap's designee AesDex LLC fully acquired Dextera's assets for $17.3 million. Redwood City, Calif.-based Dextera received about $13.6 million, and $2 million placed in escrow for 24 months. The balance of the purchase price was used to repay a $900,000 loan, make payments related to contracts and leases, and pay closing expenses.

Following the asset sale, Dextera, which developed surgical staplers and automated heart surgery systems, is no longer an operating company. The Nasdaq Stock Market suspended the trading of Dextera shares in October 2017.